U.S. Pharmaceuticals & Biotech Undervalued over 20% based on DCF

Eli Lilly

Market Cap: US$1.1t

Eli Lilly and Company discovers, develops, manufactures, and markets human pharmaceutical products in the United States, Europe, China, Japan, and internationally.

Johnson & Johnson

Market Cap: US$609.1b

Engages in the research and development, manufacture, and sale of a range of products in the healthcare field worldwide.

AbbVie

Market Cap: US$449.6b

A research-based biopharmaceutical company, engages in the research and development, manufacturing, commercializing, and sale of medicines and therapies worldwide.

Merck

Market Cap: US$314.9b

Operates as a healthcare company worldwide.

Amgen

Market Cap: US$197.7b

Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide.

Danaher

Market Cap: US$144.3b

Designs, manufactures, and markets professional, medical, research, and industrial products and services in the United States, China, and internationally.

Vertex Pharmaceuticals

Market Cap: US$123.3b

Operates as a biotechnology company in the United States, Europe, and internationally.

Agilent Technologies

Market Cap: US$37.1b

Provides application focused solutions to the life sciences, diagnostics, and applied chemical markets worldwide.

Waters

Market Cap: US$36.2b

Provides analytical workflow solutions in Asia, the Americas, and Europe.

IQVIA Holdings

Market Cap: US$34.4b

Provides clinical research services, commercial insights, and healthcare intelligence to the life sciences and healthcare industries in the Americas, Europe, Africa, and the Asia-Pacific.

Illumina

Market Cap: US$28.2b

Provides sequencing- and array-based solutions for genetic and genomic analysis in the Americas, Europe, Greater China, the Asia Pacific, the Middle East, and Africa.

ICON

Market Cap: US$13.0b

A clinical research organization, provides outsourced development and commercialization services in Ireland, Europe, the United States, and internationally.

Elanco Animal Health

Market Cap: US$12.9b

An animal health company, innovates, develops, manufactures, and markets products for pets and farm animals worldwide.

Revvity

Market Cap: US$12.3b

Provides health sciences solutions, technologies, and services.

Bruker

Market Cap: US$8.9b

Develops, manufactures, and distributes scientific instruments, and analytical and diagnostic solutions.

Alkermes

Market Cap: US$8.8b

A biopharmaceutical company, engages in the research, development, and commercialization of pharmaceutical products to address unmet medical needs of patients in therapeutic areas in the United States, Ireland, and internationally.

Qiagen

Market Cap: US$8.5b

Provides sample to insight solutions that transform biological samples into molecular insights worldwide.

Avantor

Market Cap: US$7.6b

Engages in the provision of mission-critical products and services to customers in the biopharma, healthcare, education and government, advanced technologies, and applied materials industries in the Americas, Europe, Asia, the Middle East, and Africa.

Ligand Pharmaceuticals

Market Cap: US$6.0b

A biopharmaceutical company, develops and licenses biopharmaceutical assets worldwide.

10x Genomics

Market Cap: US$5.6b

Develops and sells instruments, consumables, and software for analyzing biological systems in the United States, rest of the Americas, Europe, the Middle East, Africa, China, and the rest of the Asia Pacific.

Travere Therapeutics

Market Cap: US$5.3b

A biopharmaceutical company, identifies, develops, and delivers therapies to people living with rare kidney and metabolic diseases in the United States.

Stevanato Group

Market Cap: US$5.2b

Engages in the design, production, and distribution of products and processes to provide solutions for biopharma and healthcare industries in Europe, the Middle East, Africa, North America, South America, and the Asia Pacific.

Sotera Health

Market Cap: US$5.1b

Provides sterilization solutions, lab testing, and advisory services for the healthcare industry in the United States, Canada, Europe, and internationally.

Veracyte

Market Cap: US$4.7b

Operates as a diagnostics company in the United States and internationally.

Tango Therapeutics

Market Cap: US$4.1b

A precision oncology company, focuses on the discovery and development of drugs in defined patient populations with unmet medical need.

Adaptive Biotechnologies

Market Cap: US$3.7b

A commercial-stage company, develops an immune medicine platform for the diagnosis and treatment of various diseases.

Fortrea Holdings

Market Cap: US$1.7b

A contract research organization, provides biopharmaceutical product and medical device development solutions to pharmaceutical, biotechnology, and medical device customers worldwide.

BioLife Solutions

Market Cap: US$1.4b

Develops, manufactures, and markets bioproduction products and services for the cell and gene therapy (CGT) industry in the United States, Europe, the Middle East, Africa, and internationally.

MannKind

Market Cap: US$1.2b

A biopharmaceutical company, focuses on the provision of various solutions for transforming chronic disease care.

Theravance Biopharma

Market Cap: US$877.5m

A biopharmaceutical company, develops and commercializes medicines in the United States.

MiMedx Group

Market Cap: US$640.5m

Develops and distributes placental tissue allografts for various sectors of healthcare.

Mesa Laboratories

Market Cap: US$541.1m

Develops, designs, manufactures, sells, and services life sciences tools and quality control products and services in North America, Europe, the Asia Pacific, and internationally.

SIGA Technologies

Market Cap: US$246.7m

A commercial-stage pharmaceutical company, focuses on the health security market in the United States.

Anika Therapeutics

Market Cap: US$202.9m

A joint preservation company, focuses on early intervention orthopedics in the United States, Europe, and internationally.

Bioqual

Market Cap: US$29.1m

Provides in-vivo and in-vitro pre-clinical research services to commercial and government clients in the United States.

Pharma-Bio Serv

Market Cap: US$11.5m

Operates as a regulatory affair, compliance, and technology transfer services consulting firm in Puerto Rico, the United States, Europe, Brazil, and internationally.